Healthcare cost consciousness among physicians and their attitudes towards controlling costs in Jordan: a cross sectional study

The extent to which a patient is taking medications as prescribed by a physician is typically used to determine compliance with therapy or proper medication use. This entails a number of factors, such as the capacity to obtain medications on prescription, recalling to take medications at the proper dose and time, and understanding the instructions [1]. The rise in healthcare costs is an important barrier to patients receiving treatment. Patients feel they have limited access to the medications and treatments they need to treat their health conditions as medication prices continue to rise. This is seen as a critical issue in healthcare that has a negative impact on patient outcomes [2]. A previous study that assessed the relationship between medication cost and patient adherence showed that an increase in the patient share of medication costs was negatively associated with patient adherence to their therapy. A previous literature review that included 160 articles found that better patient clinical outcomes were associated with higher medication adherence [3]. In a a previous study evaluating cost consciousness among 2556 physicians was carried out in the United States of America (USA) in 2013, physicians demonstrated considerable responsibility for managing practice healthcare costs and generally agreed with a number of quality initiatives to reduce costs. However, they displayed less enthusiasm for cost containment involving modifications to payment methods [4]. Another study in Switzerland in 2005 found that even in a society with very high healthcare costs, physicians’ expressed cost consciousness appeared to be generally high, even though it was not evenly distributed among them [5]. Another study in the USA examined 1000 randomly chosen clinicians who were currently providing direct patient care found that most clinicians believed that only the patient and the treating clinician should make a decision on the cost-effectiveness of a clinical course of action. However, there is disagreement among clinicians over whether to deliver medical interventions with broad potential despite their high cost, and when it comes to cost-effectiveness, their patient interactions are extremely diverse [6]. In a study that examined how the cost of medications affects physicians’ decisions on what medications to prescribe, Hart et al. found that knowing about medication costs can influence a physician’s choice, which eventually lowers medication costs [7]. The best use of healthcare resources is facilitated by physicians who are more knowledgeable about the costs of medications and medical services [8]. One of the most significant factors influencing medication adherence and, ultimately, therapeutic outcomes for patients is cost. According to the latest available statistics in Jordan, around 87.3% of the Jordanian population is covered by health insurance (both private and public health insurance) [9]. Healthcare expenditure accounts for 8.4% of the gross domestic product in Jordan. In 2018, medications costs in Jordan have reached 581 million Jordanian Dinars (818.3 million USD). The aim of this study was to investigate the current state of cost consciousness among Jordanian physicians. Additionally, we sought to investigate the cost-containment strategies used by physicians in Jordan, focusing on their contribution to addressing healthcare costs as well as the consequences of cost consciousness. Understanding cost-conscious attitudes, their prevalence, and all the associated consequences will enable us to offer healthcare organizations and decision-makers suggestions and recommendations that will help to reduce the impact of any negative outcomes related to not being aware of the cost of healthcare.

This study explored the current situation regarding cost consciousness among physicians in Jordan. Additionally, it explored cost containment strategies applied by physicians in Jordan, paying attention to their role in addressing healthcare costs and the consequences of cost consciousness. The key findings are: 1) the most commonly reported bodies to have the major responsibility for reducing the cost of healthcare were the governments, health insurance companies, and pharmaceutical and device manufacturers; 2) participating physicians showed enthusiasm towards all domains of reducing healthcare costs; 3) more than 80.0% reported that uncertainty involved in patient care is disconcerting, and 70.0% reported that they order more tests when they do not know the patient well; 4) participants showed a moderate level of cost consciousness (63.6%); 5) early age (31-35 years) and having 6 to 10 years of experience were important predictors of having a high level of cost consciousness, while older age (51 years and above) and receiving their first medical degree education outside Jordan were important predictors of having a low level of cost consciousness.

Jordanian physicians’ opinions on their role in containing healthcare costs are complex. In this survey, we found that the most commonly reported bodies to have the major responsibility for reducing the cost of healthcare from the physicians’ perspective were the governments, health insurance companies, and pharmaceutical and device manufacturers. In comparison with previous studies [4, 11], it was found that physicians think the most frequently reported institutions are primarily responsible for reducing medical costs are health insurance companies, lawyers, hospitals, and healthcare systems. As for the party responsible for reducing the price of medicine, most of the physicians in the current study in Jordan agree with a previous study that the responsible authorities are the same, including the governments, health insurance companies, and pharmaceutical and device manufacturers [4]. Jordan charges a 4% tax on all pharmaceutical products, medical devices, and consumables [12]. This increases the overall cost of healthcare provision on healthcare providers themselves and, ultimately, on the patients. Apart from these general conclusions, Jordanian physicians recognized that commitments related to cost management are complicated. Their opinions in the survey are related to the place and work environment, whether in the public or private clinics, the type of specialization, and the method of payment. Health insurances in Western societies cover patients better in all aspects of healthcare, while in our societies these insurances cover part of the cost of healthcare and there are many healthcare services and medications are not covered in these insurances [13]. Therefore, we found that physicians in a previous study were in agreement that health insurance companies had more than 95% of the responsibility for lowering the cost of healthcare [4].

In Tilburt et al.’s study, 70% of physicians were “not enthusiastic” about reducing fee-for-service [4]. The results were similar in Jordan in this regard, as only around 25% were “very enthusiastic”, and 75% of the remaining physicians were either ‘not enthusiastic at all’ or “somewhat enthusiastic”. Although the income of an American physician is higher than that of a Jordanian physician, the problem exists in Jordan as well [14], and we certainly expected this result, especially since the physician’s income, as we mentioned, is lower in Jordan. The reason is for this result is typically related to the fact that physicians in Jordan finds that their income is relatively low compared to physicians in other countries.

Overall, participating physicians showed a high level of enthusiasm towards all domains (being “somewhat enthusiastic” to “very enthusiastic”), with a mean enthusiasm percentage of 88.3% (SD: 0.04). They were more enthusiastic about improving “the quality and efficiency of care”, followed by “improving conditions for evidence-based decisions”. This high percentage) 88.3% (indicates the Jordanian physicians’ awareness of the need to change for the better. This percentage compared to a previous study is close, as the American physicians showed a very high rate of enthusiasm, over 95%, about ‘promoting continuity of care’, despite the high level of medical care in the United States compared to Jordan, in addition to the availability of medical equipment and the better financial level for American physicians [4].

More than 80.0% of the participating physicians reported that they find the uncertainty involved in patient care disconcerting. A previous study in the United States found that 78% of American physicians who participated in the survey also agreed that “[their] individual patients should be devoted to the individual patients’ best treatment despite the high prices” [4]. When the physician is not fully aware of the prices or the status of his patient’s health insurance or the general financial situation of the patient, this makes the physician unable to balance matters by prescribing the optimal treatment for the patient and at the same time maintaining the financial situation and not adding large costs to the patient, who also has to pay the physician’s fee in addition to paying for medical tests in the medical laboratory and the prescribed medicines and other medical costs. In this case, the physician is uncertain because he or she wants to prescribe the best treatment for the patient but, at the same time, does not want to add large costs to the patient. A previous study in Jordan reported that the prevalence of cost-related nonadherence in Jordan is around 30.0%, and it was most common in patients with hypertension, diabetes, low incomes, and low levels of education [15].

When the Jordanian physicians were asked about cost containment and their role in containing healthcare costs around 85% of physicians showed their agreement to the statement that physicians need to take a more prominent role in limiting the use of unnecessary test. Conversely, around 70.0% of the participating physicians reported that they order more tests when they do not know the patient well. When comparing this result with the American physicians, we fond that 42% of American physicians “strongly or moderately agree”, and 58% “moderately or strongly disagree” that they do not order more tests when they do not know the patient well [4]. This result is somewhat logical, as physicians in Jordan usually request many laboratory tests, which are expensive for the patient. In addition, the reason is that, unlike in the USA, there is no electronic healthcare system that includes all patients’ clinical information in Jordan [16], and this requires the physician to ask for a higher number of tests to properly diagnose the patient. Despite the fact that we found multiple similarities in terms of physicians’ perception regarding their responsibility to reduce the cost of healthcare, their enthusiasm for reducing healthcare costs, and their role in containing healthcare costs and consequences of cost-conscious practice, it’s worth mentioning that healthcare structure and access to healthcare are different between Jordan and the USA.

Participating physicians showed a moderate level of cost consciousness with a mean score of 28.0 (SD: 2.4) out of 44, the maximum obtainable score (which is equal to 63.6%). Deep drilling and careful study of cost consciousness will have a positive impact on the patient’s life. Physicians’ awareness of healthcare costs is an important matter that includes healthcare providers’ knowledge of all matters related to the healthcare system as a whole, whether it is the cost of medications or laboratory tests, the cost of medical devices, or knowledge of the details of patients’ health insurance policies [6, 17]. By knowing these important details about healthcare costs, physicians can give the most cost-effective treatment, which will reflect positively on the patient’s health condition. If the cost to the patient remains high, this will lead to the problem of cost-related non-adherence [15].

Physicians who were aged 31–35 years and had 6 to 10 years of experience were more likely to be cost-conscious compared to others with (OR: 3.01(95% CI: 1.16–7.81)) and (OR: 3.00 (95% CI: 1.12–7.80)). On the other hand, older physicians (aged 51 years and above) and those who had received their first medical degree education outside Jordan were less likely to be cost-conscious compared to others (OR: 0.47 (95% CI: 0.28-0.78)) and (OR: 0.58 (95% CI: 0.35-0.95)), respectively. It was found in our study that young physicians were more cost-conscious as they had recently finished their study and residency programmes, which gave them updated and detailed information about medication prices and other information, so their information about Jordan medication prices was better. In addition, they were enthusiastic as they were at the beginning of their practice of medicine, and it was important for them not to raise costs on their patients and to treat them at the lowest cost in order to earn more in the future and to improve their reputation in the medical community.

In our study, we found that participating physicians showed a moderate level of cost consciousness; nevertheless, this level must be higher because it will ultimately result in cost-related nonadherence, which will have a negative impact on the health of the patient [15]. A previous study in Jordan explored cost considerations of dermatological care reported that 27.7% of the patients said their dermatologist does not go over the cost of medications with them. Additionally, about 71.4% of respondents stated that getting out-of-pocket medication expenditure estimates is crucial for them [18].

Pharmaceutical companies and healthcare organizations in Jordan should raise physicians’ awareness of costs so they can use medications most effectively and promote cost-effectiveness. This ultimately leads to better patient health outcomes as it will reduce cost-related non-adherence. These efforts should be directed mainly towards elderly physicians and those who studied outside Jordan. Pharmaceutical companies should focus on these physicians when making visits, in addition to conducting educational workshops and conferences where these physicians should be targeted.

The level of awareness among physicians must be increased by holding continuous conferences and educational seminars on the application of treatment to patients and the definition of the price of medications and their updates [19]. Decision makers in the healthcare sector, in addition to pharmaceutical companies, are advised to raise healthcare professionals’ cost-consciousness. We recommend that future studies should focus on exploring cost-consciousness in different disease areas, whether chronic or acute, to implement the appropriate cost-effective intervention, whether through medical conferences, continuing education, or instructions through the Ministry of Health.

To the best of our knowledge, this is the first study to assess the current situation regarding cost consciousness among physicians in Jordan. Our study cohort was not limited to certain specialties or practice settings (private or governmental), which will improve the generalizability of our findings. However, this study has limitations. The physicians were given online or paper-based surveys as part of a cross-sectional study design. Social desirability bias may be present in a self-administered questionnaire. As a non-probability sampling method was used in this study, the use of convenience sampling may have had an impact on how generalizable our findings were. We were unable to compare our findings with those of Middle Eastern countries with a similar healthcare environment and culture since no previous research on physicians’ cost-consciousness had been conducted in the region. Therefore, our findings should be interpreted carefully.

A moderate level of cost consciousness was found among practicing physicians in Jordan. We recommend increasing cost consciousness and doing additional research into other reasons for the lack of cost consciousness. Physicians’ awareness of healthcare prices and costs will directly reflect a better health life for patients, in addition to reducing and directing better financial spending from the government.